Seattle Genetics

Home » Seattle Genetics

Secondary

Seattle Genetics

They are a biotechnology company focused on the development and commercialization of targeted therapies for the treatment of cancer.

Symbol

SGEN

Last Closing Price
$52.30

Shares
10,400,000

Effective Date
February 1, 2018

Underwriters
Barclays, J.P. Morgan

To view the prospectus for Seattle Genetics, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC 8601 N Scottsdale Rd, Suite 335, Scottsdale, AZ 85253